Tag: Asia
-
Chewable Covid-19 Drug Reduces Viral Load, Symptoms
Clinical trial results show an experimental drug given as a chewable tablet reduces viral load and symptoms in people with mild to moderate Covid-19 disease.
-
New Venture Funds to Back Life Science, Tech Start-Ups
Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies.
-
Peptide Discovery Company to Gain $3.3B in Licensing Deals
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion.
-
AI Analytics Find New ALS Genetic Drug Targets
Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS.
-
AI Image Analysis Shown to Predict Embryo Health
An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization.
-
Roche, Global Fund to Build Local Diagnostic Processes
The medical products company Roche is partnering with the Global Fund to develop systems and processes for disease diagnostics in low-resource regions.
-
Biotech, Synthetic Bio Companies Partner on T-Cell Therapies
A company creating antibodies from synthetic DNA and a developer of engineered T-cells are collaborating on new antibodies to produce T-cell therapeutics.
-
Clinical Trial Set for AI-Driven Lung Fibrosis Drug
A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence.
-
Pharma Company Licenses Protein Delivery Hydrogel
A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue.
-
Trial Shows Immunotherapy Improves Lung Cancer Survival
Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy.